Abstract:The identification of tumor related membrane protein is important for both cancer diagnosis and targeted therapy. Currently, the number of ideal clinical biomarkers is still limited partially because of lacking efficient methods in biomarker discovery. Targeting peptides are generated by library screening and can recognize their cognate targets with high specificity and affinity. In addition, these functional peptides have been considered to be a valuable molecule for both imaging detection and targeting therapy in oncology. The selected peptides can be used to identify cell-surface protein biomarkers of cancer cells. In our study, the peptide (VECYLIRDNLCIY) derived from the bacteria displaying library worked as a bait to capture its binding partner and aldolase A was identified as the candidate. The results indicated that aldolase A' expression level on the cell membrane was regulated by PI3K and aldolase A located on the membrane could inhibit the aggression of tumors through mediating cell metabolic pathway. Aldolase A could work as the joint for the metabolic and signal pathways related to tumor progression. In our work, we demonstrated a promising technology for selecting and identifying binding partners for cell-specific peptides that enables discovery of new tumor biomarkers, showing great scientific study values and clinical translation potencies. SIGNIFICANCE: MS-based cancer biomarker discovery provides promising target candidates for cancer diagnosis and therapy. However, the inevitable limits make it inconvenient in the process of sample preparation and data analysis. In this way, the small molecular probes show some advantages due to their readily availability and specific binding affinity such as the aptamers screened with SELEX technology and peptides derived from displaying libraries. In the present study, aldolase A was proved to be the membrane binding partner of a specific peptidic ligand towards ZR-75-1 tumor cell. It was discovered that membrane aldolase A was more sensitive and observable than other subcellular fractions in response to cellular metabolic state alteration or glucose availability. In addition, the reduced membrane-localized aldolase A expression indicated a more aggressive tumor phenotype and was accompanied by the upregulation of MMP-2/MMP-9. The non-glycolysis activity endowed it with potential utility as a tumor diagnostic marker and therapeutic target. This work demonstrates the practicability of screened peptide in cancer biomarker discovery, facilitating the development of diagnostic tools and therapeutic approaches to cancer, and markedly improves our understanding of cancer biology.

Preliminary Research of the Correlation Between Membrane Fluidity and Protein Kinase C in Cancer Cell

Correlation between CD44 and membrane fluidity—a study on biopsies of high-grade serous ovarian tumor

Correlation of Plasma Membrane Microviscosity and Cell Stiffness Revealed via Fluorescence-Lifetime Imaging and Atomic Force Microscopy

[Cell membrane phospholipid variation and protein kinase C expression effects on hepatic metastasis of large intestinal carcinoma]

Involvement of AMP-activated Protein Kinase (AMPK) in Regulation of Cell Membrane Potential in a Gastric Cancer Cell Line

Three-Dimensional Measurement of the Mechanical Fields and Fiber Structure Around Cancer Cells Co-Cultured with CAFs

Lipid Membrane Alterations in Tumor Spheroids Revealed by Fluorescence Lifetime Microscopy Imaging

Quantification of Microvascular Dentsity and Cell Nuclear DNA Content in Laryngeal Cancer

Development of a Microscopy-Based Assay for Protein Kinase Cζ Activation in Human Breast Cancer Cells

Cancer‐Specific Therapy by Artificial Modulation of Intracellular Calcium Concentration

Advances on the Relationship Between Plasma Membrane Protein and Tumor

The research on expression and mechanism of Ca2+/calmodulin-dependent protein kinaseδin colorectal cancer

Application of TEM: Dynamic changes of AKAP95-Cx43 complex during G1 phase of lung cancer cells

Correlation Between Membrane Proteins and Sizes of Extracellular Vesicles and Particles: A Potential Signature for Cancer Diagnosis.

AFM‐Based Poroelastic@Membrane Analysis of Cells and its Opportunities for Translational Medicine

Identification of Cancer Protein Biomarker Based on Cell Specific Peptide and Its Potential Role in Predicting Tumor Metastasis.

Studies on Fluidity of Lens Cell Membrane and Pathogenesis of Cataract

Correlation between tumor cell migration and formaldehyde levels revealed by fluorescence imaging

Visualizing in vitro-in vivo correlation of miktoarm copolymer nanomicelles in cancer cellular uptake and trafficking

Detection of Membrane Receptors on Per Tumor Cell by Nonimmobilized Cell Capillary Electrophoresis and a Mathematic Model

Ultrasensitive Fluorescent Probes Reveal an Adverse Action of Dipeptide Peptidase IV and Fibroblast Activation Protein During Proliferation of Cancer Cells.